The changing burden of pediatric bloodstream infections in Calgary, Canada, 2000-2006

Pediatric Infectious Disease Journal

Volumn 28, Issue 2, 2009, Pages 114-117

  Laupland, Kevin B ^a,b,c   Gregson, Daniel B ^a,b   Vanderkooi, Otto G ^a   Ross, Terry ^b   Kellner, James D ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c FOOTHILLS HOSPITAL   (Canada)

Author keywords

Bacteremia; Incidence; Mortality; Surveillance

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADOLESCENT; ARTICLE; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CANADA; CHILD; CHILDHOOD MORTALITY; CLINICAL FEATURE; COMMUNICABLE DISEASE; ESCHERICHIA COLI; FEMALE; HEALTH SURVEY; HOSPITAL INFECTION; HUMAN; IMMUNIZATION; INCIDENCE; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NEWBORN; OUTCOME ASSESSMENT; PNEUMOCOCCAL INFECTION; POPULATION RESEARCH; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; AGE DISTRIBUTION; BACTEREMIA; COHORT ANALYSIS; PRESCHOOL CHILD; SEX DIFFERENCE; TIME;

ADOLESCENT; AGE DISTRIBUTION; ALBERTA; BACTEREMIA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; SEX FACTORS; TIME FACTORS;

EID: 61949235288     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318187ad5a     Document Type: Article

References (31)

1. Laupland KB, Gregson DB, Flemons WW, et al. Burden of community-onset bloodstream infection: a population-based assessment. Epidemiol Infect.2007;135:1037-1042.
2. Bettinger JA, Scheifele DW, Halperin SA, et al. Invasive pneumococcal infections in Canadian children, 1998-2003: implications for new vaccination programs. Can J Public Health.2007;98:111-115.
3. Gur E, Frank M, Givon-Lavi N, et al. Community-acquired bloodstream infections in children >one month old in southern Israel (1992-2001): epidemiological, clinical and microbiological aspects. Scand J Infect Dis.2006;38:604-612.
4. Kellner JD, Church DL, MacDonald J, et al. Progress in the prevention of pneumococcal infection. CMAJ.2005;173:1149-1151.
5. Herz AM, Greenhow TL, Alcantara J, et al. Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine. Pediatr Infect Dis J.2006;25:293-300.
6. Bruce MG, Deeks SL, Zulz T, et al. International Circumpolar Surveillance System for invasive pneumococcal disease, 1999 -2005. Emerg Infect Dis.2008;14:25-33.
7. De Wals P, Deceuninck G, Boulianne N, et al. Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine. JAMA.2004;292:2491-2494.
8. Poehling KA, Talbot TR, Griffin MR, et al. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA.2006;295:1668-1674.
9. Scheifele D, Bell A, Jadavji T, et al. Population-based surveillance of Hib invasive infections in children in British Columbia Alberta and Ontario-1995 to 1997. Can JInfect Dis.2000;11:135-140.
10. Hyde TB, Hilger TM, Reingold A, et al. Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics.2002;110:690-695.
11. Davies HD, Adair CE, Schuchat A, et al. Physicians' prevention practices and incidence of neonatal group B streptococcal disease in 2 Canadian regions. CMAJ.2001;164:479-485.
12. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureusin children with no identified predisposing risk. JAMA.1998;279:593-598.
13. Seal JB, Moreira B, Bethel CD, et al. Antimicrobial resistance in Staphylococcus aureusat the University of Chicago Hospitals: a 15-year longitudinal assessment in a large university-based hospital. Infect Control Hosp Epidemiol2003;24: 403-408.
14. Purcell K, Fergie J. Epidemic of community-acquired methicillin-resistant Staphylococcus aureusinfections: a 14-year study at Driscoll Children's Hospital. Arch Pediatr Adolesc Med.2005;159:980-985.
15. Chuang YY, Huang YC, Lee CY, et al. Methicillin-resistant Staphylococcus aureusbacteraemia in neonatal intensive care units: an analysis of 90 episodes. Acta Paediatr.2004;93:786-790.
16. Khairulddin N, Bishop L, Lamagni TL, et al. Emergence of methicillin resistant Staphylococcus aureus(MRSA) bacteraemia among children in England and Wales, 1990-2001. Arch Dis Child.2004;89:378-379.
17. Laupland KB, Davies HD, Low DE, et al, for the Ontario Group A Streptococcal Study Group. Invasive group a streptococcal disease in children and association with varicella-zoster virus infection. Pediatrics. 2000;105:E60.
18. Madsen KM, Schonheyder HC, Kristensen B, et al. Secular trends in incidence and mortality of bacteraemia in a Danish county 1981-1994. APMIS.1999;107:346-352.
19. Pedersen G, Schonheyder HC, Sorensen HT. Source of infection and other factors associated with case fatality in community-acquired bacteremia-a Danish population-based cohort study from 1992 to 1997. Clin Microbiol Infect.2003;9:793-802.
20. Skogberg K, Lyytikainen O, Ruutu P, et al. Increase in bloodstream infections in Finland, 1995-2002. Epidemiol Infect.2008;136:108-114.
21. Uslan DZ, Crane SJ, Steckelberg JM, et al. Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Arch Intern Med.2007;167:834-839.
22. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl JMed.2003;348:1737-1746.
23. Trick WE, Zagorski BM, Tokars JI, et al. Computer algorithms to detect bloodstream infections. Emerg Infect Dis.2004;10:1612-1620.
24. Medical Officer of Health, Calgary Health Region. Health of the Region, 2006. Available at: http://www.calgaryhealthregion.ca/communications/ regionhealth/index.htm. Accessed April 26, 2007.
25. Laupland KB, Ross T, Pitout JD, et al. Investigation of sources of potential bias in laboratory surveillance for anti-microbial resistance. Clin Invest Med.2007;30:E159-E166.
26. Garner JS, Jarvis WR, Emori TG CDC definitions for nosocomial infections. In: Olmsted RN, ed. APIC Infection Control and Applied Epidemiology: Principles and Practice.St. Louis, MO: Mosby; 1996:A-1-A-20.
27. Population by Alberta Regional Health Authorities. Health Systems Analysis Unit, Calgary Health Region. Available at: http://www. calgaryhealthregion.ca/qshi/hsau/Demographic-Data/DemographicData.html. Accessed February 4, 2008.
28. Singleton RJ, Hennessy TW, Bulkow LR, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valentpneumococcal conjugate vaccinecoverage. JAMA.2007;297: 1784-1792.
29. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR Morb Mortal Wkly Rep.2005; 54:893-897.
30. Baltimore RS, Huie SM, Meek JI, et al. Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics.2001;108:1094-1098.
31. Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med.2000;342: 15-20.